CDRO vs GENI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
CDRO
GENI
Investment Advisor Scores
GENI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDRO | GENI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.587 | 55.2486 | CDRO |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 18.4% | 62.3% | GENI |
| Earnings Growth | 15.8% | 0.0% | CDRO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 63.5/100 | 54.8/100 | CDRO |
| Profit Margin | 4.4% | -18.9% | CDRO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | HOLD | CDRO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDRO
MarkdownPrice below a falling SMA50 (slope -0.2%), weak momentum, RSI 42
GENI
MarkdownPrice below a falling SMA50 (slope -7.8%), weak momentum, RSI 45
Fundamentals Snapshot
| Metric | CDRO | GENI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 14.1 | 5.8 |
| Trailing P/E | 33.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.6% |
| Gross Margin | 0.9% | 0.3% |
| Operating Margin | 0.0% | -0.1% |
| EPS | 0.26 | -0.61 |
| Dividend Yield | — | — |